ECCRT “What is the future in Clinical and Pharmacovigilance Quality Management?” 2020 – Attended by ADAMAS. ADAMAS will be proudly attending the ECCRT 2020 Conference which will be held at the Faculty Club – Groot Begijnhof 14, 3000 Leuven, Belgium on the 29th &...
We would like to thank you all for following our blog over the course of the last year and hope you will continue to do so in 2017. Please click the link below to see our Christmas Card. Click here to see the ADAMAS Christmas Card Hoping you all have a Merry Christmas...
21CFR11 Compliance of Third-Party Computer Systems
The development of medicines is the most regulated industry in the world, and compliance at each stage of the research and development process, as well as after licensing, is critical to ensuring high quality and safe medicines reach patients in a timely manner.
ADAMAS’s consultants have expertise across the G’X’Ps in pre-clinical, clinical and post-licensing areas. They have worked across many different therapeutic areas and product types including oncology, vaccines, biologics, medical devices and gene therapy. As a company we have developed close partnerships with our clients to support them in their development programmes and post-licensing activities, and to guide them successfully through their worldwide regulatory inspections.